Japan Implements Revised Regulations for Genetically Modified Foods without Safety Assessment
In a recent development, the Ministry of Health, Labour and Welfare in Japan has announced the implementation of revised regulations pertaining to the inspection methods for genetically modified (GM) foods that have not undergone safety assessments. This decision, outlined in the Health and Sanitary Notification No. 3 of 2028 released on March 28, 2024, focuses on the genetic testing of imported food products.
Under the revised regulations, specific genetic elements will be targeted for testing in certain food categories. Notably, for rice-based products such as rice flour and minimally processed rice products, the designated genetic elements for inspection include 63Bt, NNBt, and CpTI. Additionally, for papaya and its processed products, the inspection will be conducted for the presence of PRSV-YK and PRSV-HN, limited to the separable parts of the papaya.
The revised regulations aim to strengthen the scrutiny of imported food items that have not undergone safety assessments for genetically modified organisms (GMOs). By implementing the revised "Inspection Methods for Genetically Modified Foods without Safety Assessment," Japan seeks to ensure the safety and proper labeling of GM food products entering its market.
Japan's recent revision of regulations pertaining to the inspection of genetically modified foods sets forth a rigorous framework for scrutinizing imported food products lacking safety assessments for GMOs. By targeting specific genetic elements in rice-based and papaya products, Japan aims to enhance consumer safety and transparency in the food market. These measures reflect Japan's commitment to maintaining a stringent regulatory environment and ensuring the well-being of its consumers.
2026-09-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
FDA Tracks Industry Dye Removal
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
India Prepares New Seed and Pesticide Laws
-
Syngenta Caught in Trade Crossfire
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
Recommend Reading
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
Business Society’s Market Outlook for Epichlorohydrin on August 27, 2026: Strong Consolidation (Bullish)
-
This week, the market price of propylene oxide in China has increased (11.3-11.6)
-
Chinese Urea Market Continues Weak Trend (7.10-7.16)
-
Business Society’s Market Outlook for Formic Acid on August 28, 2026: Rising
-
The relationship between Digital Transformation and Work- Life Balance in the Egyptian Pharmaceutical Industry